Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Compliance × Anastrozole × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 197 Neoplasm Metastasis 14 Neoplasms 12 Carcinoma, Intraductal, Noninfiltrating 8 Advanced Breast Cancer 7 Breast Neoplasms, Male 6 Breast Diseases 5 Breast Carcinoma In Situ 5 Triple Negative Breast Neoplasms 4 Endometrial Neoplasms 4 Arthralgia 4 Ovarian Neoplasms 3 Breast Cancer Metastatic 3 Recurrence 2 Osteoporosis 2 Obesity 2 Neoplasms by Site 2 Multiple Endocrine Neoplasia Type 1 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Skin Diseases 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1 Quality of Life 1 Prostatic Neoplasms 1 Patient Compliance 1 Pancreatic Neoplasms 1

Interventions

Exercise 3 Patient Navigation 2 Interviews as Topic 2 regorafenib 1 potassium oxonate 1 beta-Aminoethyl Isothiourea 1 Weights and Measures 1 Videotape Recording 1 Trastuzumab 1 Surveys and Questionnaires 1 Standard of Care 1 Radiation 1 Psychosocial Intervention 1 Oxaliplatin 1 Ocoxin 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Metabolism 1 Leuprolide 1 Lapatinib 1 Goserelin 1 Diet 1 Clodronic Acid 1 Cisplatin 1 Capecitabine 1 Anastrozole 1 Acupuncture Points 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00555867 2011-12-23

PACT

AstraZeneca

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡